Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,550.00
-30.00 (-0.54%)
At close: Apr 23, 2025, 3:30 PM KST

Kyongbo Pharmaceutical Market Cap

Kyongbo Pharmaceutical has a market cap or net worth of 132.44 billion as of April 25, 2025. Its market cap has decreased by -23.59% in one year.

Market Cap
132.44B
Enterprise Value
217.75B
Revenue
238.56B
Ranking
n/a
PE Ratio
28.56
Stock Price
5,550.00

Market Cap Chart

Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 132.44B, a decrease of -83.82%. That is a compound annual growth rate of -16.92%.

History

DateMarket Cap% Change
Apr 25, 2025132.44B-10.93%
Dec 30, 2024148.70B-25.86%
Dec 28, 2023200.58B-16.10%
Dec 29, 2022239.07B-6.98%
Dec 30, 2021257.00B-34.25%
Dec 30, 2020390.88B97.94%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 73.67T
Celltrion 33.84T
ALTEOGEN 19.67T
Yuhan 8,608.63B
SK Biopharmaceuticals 8,081.93B
HLB Co., Ltd. 7,240.39B
Peptron 4,063.06B
LigaChem Biosciences 4,045.44B
Market Cap Rankings